Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 03, 2023 08:00 ET | Source: Infinera Corporation

Infinera Appoints Industry Veteran Scotty Benda as Senior Vice President of Worldwide Systems Engineering

SAN JOSE, Calif., July 03, 2023 (GLOBE NEWSWIRE) -- Infinera (NASDAQ: INFN) announced today that Scotty Benda has joined Infinera as Senior Vice President of Worldwide Systems Engineering. In this...
July 03, 2023 06:01 ET | Source: Zealand Pharma

Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396

Company announcement – No. 27 / 2023 Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396 Doses of 0.6 and 1.2 mg ZP8396...
June 30, 2023 16:30 ET | Source: Integra Resources Corp.

Voting Results for the Annual General Meeting of Shareholders Held on June 30, 2023

VANCOUVER, British Columbia, June 30, 2023 (GLOBE NEWSWIRE) -- Integra Resources Corp. (“Integra” or the “Company”) is pleased to report the voting results from its Annual General Meeting of...
June 30, 2023 13:39 ET | Source: Service Federal Credit Union

Service CU Impact Foundation Announces Robert Irvine Culinary Impact Scholarship

PORTSMOUTH, N.H., June 30, 2023 (GLOBE NEWSWIRE) -- The Service CU Impact Foundation, a 501(c)3 non-profit charity arm of Service Credit Union, is excited to announce a new scholarship dedicated to...
June 30, 2023 13:32 ET | Source: Zealand Pharma

Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism

Press release – No. 8 / 2023 Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism Copenhagen, Denmark, June 30, 2023 – Zealand Pharma A/S...
June 30, 2023 11:05 ET | Source: Zealand Pharma

Total number of shares and voting rights in Zealand Pharma at June 30, 2023

Company announcement – No. 26 / 2023 Total number of shares and voting rights in Zealand Pharma at June 30, 2023 Copenhagen, Denmark, June 30, 2023 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL)...
June 30, 2023 02:00 ET | Source: Samsung Bioepis

Samsung Bioepis Releases 2023 Sustainability Report

Highlights key initiatives that will drive the company’s transition towards a more sustainable businessReaffirms commitment to environmentally and socially responsible practices in R&D, clinical...
June 30, 2023 01:00 ET | Source: Ipsen Pharma

Ipsen et GENFIT annoncent les résultats positifs de l'essai de Phase III ELATIVE évaluant elafibranor chez des patients atteints de cholangite biliaire primitive, une maladie cholestatique rare du foie

L'essai a atteint le critère d'évaluation principal, avec un pourcentage statistiquement supérieur de patients ayant observé une évolution cliniquement significative de la cholestase par rapport au...
June 30, 2023 01:00 ET | Source: GENFIT S.A.

Ipsen et GENFIT annoncent les résultats positifs de l'essai de Phase III ELATIVE® évaluant elafibranor chez des patients atteints de cholangite biliaire primitive, une maladie cholestatique rare du foie

L'essai a atteint le critère d'évaluation principal, avec un pourcentage statistiquement supérieur de patients ayant observé une évolution cliniquement significative de la cholestase par rapport au...
June 30, 2023 01:00 ET | Source: GENFIT S.A.

Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE® trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease

Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically meaningful cholestasis response compared to placeboElafibranor was well tolerated with...